Annual report
4565.TEDINET S100QFQ7
Period2022-01-01 → 2022-12-31
Filed2023-03-23
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 142
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥15.6bn | 2022-01-01 → 2022-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥17.7bn | 2021-01-01 → 2021-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥8.8bn | 2020-01-01 → 2020-12-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥9.7bn | 2019-01-01 → 2019-12-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥2.9bn | 2018-01-01 → 2018-12-31d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥3.4bn | 2022-01-01 → 2022-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥3.8bn | 2021-01-01 → 2021-12-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥1.1bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥433m | 2021-01-01 → 2021-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥1.6bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥534m | 2019-01-01 → 2019-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | −¥7.2bn | 2018-01-01 → 2018-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥382m | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥1.0bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥1.5bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥1.4bn | 2019-01-01 → 2019-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | −¥6.0bn | 2018-01-01 → 2018-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥382m | 2022-01-01 → 2022-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥1.0bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss IFRS |
| Total assets | ¥99.4bn | at 2022-12-31 | Cons. | Assets IFRS |
| Total assets | ¥97.0bn | at 2021-12-31 | Cons. | Assets IFRS |
| Total assets | ¥76.5bn | at 2020-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥56.7bn | at 2019-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥59.0bn | at 2018-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥41.5bn | at 2022-12-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥39.5bn | at 2021-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥57.9bn | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥57.5bn | at 2021-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥52.4bn | at 2020-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥57.9bn | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥57.5bn | at 2021-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥52.4bn | at 2020-12-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥45.1bn | at 2019-12-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥41.6bn | at 2018-12-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥66.6bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥60.1bn | at 2021-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥40.0bn | at 2020-12-31d | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥15.4bn | at 2019-12-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥18.8bn | at 2018-12-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥10.0bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥7.1bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥4.7bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥3.4bn | 2019-01-01 → 2019-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | −¥4.0bn | 2018-01-01 → 2018-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | ¥1.0bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | ¥278m | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥150m | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥246m | 2019-01-01 → 2019-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥2.8bn | 2018-01-01 → 2018-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥4.9bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥11.1bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥20.3bn | 2020-01-01 → 2020-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥7.0bn | 2019-01-01 → 2019-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥2.3bn | 2018-01-01 → 2018-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥4.68 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥12.53 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥18.77 | 2020-01-01 → 2020-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥18.7 | 2019-01-01 → 2019-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥-78.4 | 2018-01-01 → 2018-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥4.63 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥12.4 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥18.59 | 2020-01-01 → 2020-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥18.5 | 2019-01-01 → 2019-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥-78.4 | 2018-01-01 → 2018-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥707.2 | at 2022-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥704.97 | at 2021-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥649.92 | at 2020-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥584.83 | at 2019-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥544.89 | at 2018-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 58.3% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 59.3% | at 2021-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 68.5% | at 2020-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 79.5% | at 2019-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 70.5% | at 2018-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 0.7% | 2022-01-01 → 2022-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 1.9% | 2021-01-01 → 2021-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 3.0% | 2020-01-01 → 2020-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 3.3% | 2019-01-01 → 2019-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | -13.2% | 2018-01-01 → 2018-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 202 | at 2022-12-31 | Cons. | Number of employees |
| Employees | 198 | at 2021-12-31 | Cons. | Number of employees |
| Employees | 190 | at 2020-12-31d | Cons. | Number of employees |
| Employees | 163 | at 2019-12-31d | Cons. | Number of employees |
| Employees | 169 | at 2018-12-31d | Cons. | Number of employees |
| Revenue | ¥1.1bn | 2022-01-01 → 2022-12-31 | Standalone | Operating revenue1 |
| Revenue | ¥823m | 2021-01-01 → 2021-12-31 | Standalone | Operating revenue1 |
| Revenue | ¥433m | 2020-01-01 → 2020-12-31d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥675m | 2019-01-01 → 2019-12-31d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥819m | 2018-01-01 → 2018-12-31d | Standalone | Operating revenue1 (5-year summary) |
| Operating income | −¥1.1bn | 2022-01-01 → 2022-12-31 | Standalone | Operating income |
| Operating income | −¥1.2bn | 2021-01-01 → 2021-12-31 | Standalone | Operating income |
| Ordinary income | −¥1.6bn | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥4.7bn | 2021-01-01 → 2021-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥1.4bn | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥764m | 2019-01-01 → 2019-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥2.1bn | 2018-01-01 → 2018-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥1.4bn | 2022-01-01 → 2022-12-31 | Standalone | Income before income taxes |
| Profit before tax | −¥4.3bn | 2021-01-01 → 2021-12-31 | Standalone | Income before income taxes |
| Net income | −¥1.5bn | 2022-01-01 → 2022-12-31 | Standalone | Profit loss |
| Net income | −¥4.3bn | 2021-01-01 → 2021-12-31 | Standalone | Profit loss |
| Net income | −¥1.3bn | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥504m | 2019-01-01 → 2019-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥2.5bn | 2018-01-01 → 2018-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥89.4bn | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥94.3bn | at 2021-12-31 | Standalone | Assets |
| Total assets | ¥78.9bn | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥59.2bn | at 2019-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥66.4bn | at 2018-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥31.8bn | at 2022-12-31 | Standalone | Liabilities |
| Total liabilities | ¥35.9bn | at 2021-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥57.5bn | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥58.5bn | at 2021-12-31 | Standalone | Net assets |
| Net assets / equity | ¥61.5bn | at 2020-12-31d | Standalone | Net assets |
| Net assets / equity | ¥58.1bn | at 2019-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥57.7bn | at 2018-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥39.1bn | at 2022-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥44.1bn | at 2021-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-18.3 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-52.47 | 2021-01-01 → 2021-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-16.62 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-6.57 | 2019-01-01 → 2019-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-32.79 | 2018-01-01 → 2018-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥699.45 | at 2022-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥714.03 | at 2021-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥754.79 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥735.13 | at 2019-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥732.78 | at 2018-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 64.1% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.7% | at 2021-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.1% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 95.7% | at 2019-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 84.2% | at 2018-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 81,923,230 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 81,518,316 | at 2021-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 80,596,128 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 77,073,136 | at 2019-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 76,301,936 | at 2018-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 32 | at 2022-12-31 | Standalone | Number of employees |
| Employees | 30 | at 2021-12-31 | Standalone | Number of employees |
| Employees | 23 | at 2020-12-31d | Standalone | Number of employees |
| Employees | 19 | at 2019-12-31d | Standalone | Number of employees |
| Employees | 19 | at 2018-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 1,364
| Item | Context | Value | Unit |
|---|---|---|---|
| Term of office information about executive directors | FilingDateInstant_jpcrp030000-asr_E00981-000ChristopherCargillMember | Original text (Japanese)(注) | |
| Official title or position information about executive directors | FilingDateInstant_jpcrp030000-asr_E00981-000NomuraHironoshinMember | Original text (Japanese)執行役副社長CFO | |
| Name information about executive directors | FilingDateInstant_jpcrp030000-asr_E00981-000NomuraHironoshinMember | Original text (Japanese)野村 広之進 | |
| Date of birth information about executive directors | FilingDateInstant_jpcrp030000-asr_E00981-000NomuraHironoshinMember | 1983-11-26 | |
| Career summary information about executive directors (text) | FilingDateInstant_jpcrp030000-asr_E00981-000NomuraHironoshinMember | Text · Plus | |
| Term of office information about executive directors | FilingDateInstant_jpcrp030000-asr_E00981-000NomuraHironoshinMember | Original text (Japanese)(注) | |
| Official title or position information about executive directors | FilingDateInstant_jpcrp030000-asr_E00981-000KieranJohnsonMember | Original text (Japanese)執行役副社長CAO(チーフ・アカウンティング・オフィサー) | |
| Name information about executive directors | FilingDateInstant_jpcrp030000-asr_E00981-000KieranJohnsonMember | Original text (Japanese)キーラン・ジョンソン | |
| Date of birth information about executive directors | FilingDateInstant_jpcrp030000-asr_E00981-000KieranJohnsonMember | 1969-05-13 | |
| Career summary information about executive directors (text) | FilingDateInstant_jpcrp030000-asr_E00981-000KieranJohnsonMember | Text · Plus | |
| Term of office information about executive directors | FilingDateInstant_jpcrp030000-asr_E00981-000KieranJohnsonMember | Original text (Japanese)(注) | |
| Official title or position information about executive directors | FilingDateInstant_jpcrp030000-asr_E00981-000YoshizumiKazuhikoMember | Original text (Japanese)執行役副社長CCO(チーフ・コンプライアンス・オフィサー) | |
| Name information about executive directors | FilingDateInstant_jpcrp030000-asr_E00981-000YoshizumiKazuhikoMember | Original text (Japanese)吉住 和彦 | |
| Date of birth information about executive directors | FilingDateInstant_jpcrp030000-asr_E00981-000YoshizumiKazuhikoMember | 1954-02-19 | |
| Career summary information about executive directors (text) | FilingDateInstant_jpcrp030000-asr_E00981-000YoshizumiKazuhikoMember | Text · Plus | |
| Term of office information about executive directors | FilingDateInstant_jpcrp030000-asr_E00981-000YoshizumiKazuhikoMember | Original text (Japanese)(注) | |
| Official title or position information about executive directors | FilingDateInstant_jpcrp030000-asr_E00981-000MatthewBarnesMember | Original text (Japanese)執行役副社長 | |
| Name information about executive directors | FilingDateInstant_jpcrp030000-asr_E00981-000MatthewBarnesMember | Original text (Japanese)マシュー・バーンズ | |
| Date of birth information about executive directors | FilingDateInstant_jpcrp030000-asr_E00981-000MatthewBarnesMember | 1973-05-02 | |
| Career summary information about executive directors (text) | FilingDateInstant_jpcrp030000-asr_E00981-000MatthewBarnesMember | Text · Plus | |
| Term of office information about executive directors | FilingDateInstant_jpcrp030000-asr_E00981-000MatthewBarnesMember | Original text (Japanese)(注) | |
| Official title or position information about executive directors | FilingDateInstant_jpcrp030000-asr_E00981-000CandelleChongMember | Original text (Japanese)執行役副社長CEO室長 | |
| Name information about executive directors | FilingDateInstant_jpcrp030000-asr_E00981-000CandelleChongMember | Original text (Japanese)キャンデル・チョン | |
| Date of birth information about executive directors | FilingDateInstant_jpcrp030000-asr_E00981-000CandelleChongMember | 1989-10-16 | |
| Career summary information about executive directors (text) | FilingDateInstant_jpcrp030000-asr_E00981-000CandelleChongMember | Text · Plus | |
| Term of office information about executive directors | FilingDateInstant_jpcrp030000-asr_E00981-000CandelleChongMember | Original text (Japanese)(注) | |
| Footnotes executive officers (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Outside directors and outside corporate auditors (text) | FilingDateInstant | Text · Plus | |
| Audits (text) | FilingDateInstant | Text · Plus | |
| Remuneration for directors and other officers (text) | FilingDateInstant | Text · Plus | |
| Remuneration etc paid by group to each director or other officer (text) | FilingDateInstant | Text · Plus | |
| Shareholdings (text) | FilingDateInstant | Text · Plus | |
| Name of group company holding largest amount of investment shares in group | CurrentYearInstant | Heptares Therapeutics Ltd. | |
| Reason for increase in number of shares shares not listed investment shares held for purposes other than pure investment largest holding company | CurrentYearDuration | - | |
| Reason for increase in number of shares shares other than those not listed investment shares held for purposes other than pure investment largest holding company | CurrentYearDuration | Original text (Japanese)保有していた株式の公開買付に応じる取引の一環として、スピンアウト会社の株式を取得 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment largest holding company | CurrentYearInstant_Row1Member | Centassa Pharmaceuticals PLC | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row1Member | Original text (Japanese)(保有目的)取得した対価の価値を最大化するために保有しております。 (定量的な保有効果)(注)2 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row1Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment largest holding company | CurrentYearInstant_Row2Member | Biohaven Pharmaceutical Holding Company Ltd. | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row2Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row2Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment largest holding company | CurrentYearInstant_Row3Member | Biohaven Ltd. | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row3Member | Text · Plus | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row3Member | Original text (Japanese)無 | |
| Description of fact that consolidated financial statements have been prepared in accordance with IFRS financial information | CurrentYearDuration | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Description of fact that financial statements have been prepared in accordance with special provision financial information | CurrentYearDuration | Original text (Japanese)また、当社は、特例財務諸表提出会社に該当し、財務諸表等規則第127条の規定により財務諸表を作成しております。 | |
| Note on independent audit financial information | CurrentYearDuration | Text · Plus | |
| Remarkable efforts to ensure fair presentation of consolidated financial statements etc and internal system to prepare consolidated financial statements etc fairly in accordance with IFRS financial information | CurrentYearDuration | Text · Plus | |
| Consolidated statement of financial position IFRS (text) | CurrentYearDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 21 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |